MoonLake shareholders elect all director nominees and approve auditor and say-on-pay at AGM

MoonLake Immunotherapeutics

All three Class III director nominees elected: Dr. Jorge Santos da Silva, Simon Sturge, Dr. Andrew Phillips with over 53M votes for each.
Ratification of Baker Tilly US, LLP as independent auditor approved: 59,310,209 for, 2,856 against, 8,438 abstentions.
Advisory vote on executive compensation passed with 53,464,199 for, 109,913 against, 8,983 abstentions, 5,738,408 broker non-votes.
Total shares entitled to vote: 63,474,253 Class A and 729,320 Class C ordinary shares as of record date April 10, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.